Marino, A.; Campanella, E.; Stracquadanio, S.; Calvo, M.; Migliorisi, G.; Nicolosi, A.; Cosentino, F.; Marletta, S.; Spampinato, S.; Prestifilippo, P.;
et al. Ceftazidime/Avibactam and Meropenem/Vaborbactam for the Management of Enterobacterales Infections: A Narrative Review, Clinical Considerations, and Expert Opinion. Antibiotics 2023, 12, 1521.
https://doi.org/10.3390/antibiotics12101521
AMA Style
Marino A, Campanella E, Stracquadanio S, Calvo M, Migliorisi G, Nicolosi A, Cosentino F, Marletta S, Spampinato S, Prestifilippo P,
et al. Ceftazidime/Avibactam and Meropenem/Vaborbactam for the Management of Enterobacterales Infections: A Narrative Review, Clinical Considerations, and Expert Opinion. Antibiotics. 2023; 12(10):1521.
https://doi.org/10.3390/antibiotics12101521
Chicago/Turabian Style
Marino, Andrea, Edoardo Campanella, Stefano Stracquadanio, Maddalena Calvo, Giuseppe Migliorisi, Alice Nicolosi, Federica Cosentino, Stefano Marletta, Serena Spampinato, Pamela Prestifilippo,
and et al. 2023. "Ceftazidime/Avibactam and Meropenem/Vaborbactam for the Management of Enterobacterales Infections: A Narrative Review, Clinical Considerations, and Expert Opinion" Antibiotics 12, no. 10: 1521.
https://doi.org/10.3390/antibiotics12101521
APA Style
Marino, A., Campanella, E., Stracquadanio, S., Calvo, M., Migliorisi, G., Nicolosi, A., Cosentino, F., Marletta, S., Spampinato, S., Prestifilippo, P., Stefani, S., Cacopardo, B., & Nunnari, G.
(2023). Ceftazidime/Avibactam and Meropenem/Vaborbactam for the Management of Enterobacterales Infections: A Narrative Review, Clinical Considerations, and Expert Opinion. Antibiotics, 12(10), 1521.
https://doi.org/10.3390/antibiotics12101521
